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Key findings:
• In 2019, 61% of WA participants reported recent use of nitrous oxide; the highest 
proportion observed since data collection commenced.• Nitrous oxide was used on a median of 10 occasions in the preceding six months 
(increasing significantly from 2018) and one in four consumers reported weekly use.• The median amount used in a ‘typical’ session was 10 bulbs, while the maximum 
median used in a session was 25 bulbs.• Increasing trends in the use of this inhalant raise concern about the risk of 
associated harms, particularly neurological damage associated with vitamin B12 
depletion. • These findings suggest there may be a need for a targeted education/harm 
reduction campaign. There may also be a need to review existing regulation to 
reduce risks associated with 24/7 delivery services/promotions. 
Background
There have been some indications that recreational use of nitrous oxide (also known 
as ‘nangs’, ‘whippets’, laughing gas, balloons, NOS and N20) and associated harms 
may be increasing in Australia and elsewhere (e.g. 1-6). Whilst having a very long 
history of recreational use (7) and a reputation of being relatively harmless, a growing 
number of case reports/series are documenting significant adverse effects associated 
with prolonged or frequent recreational use (4, 5, 8-12). The seemingly increasing 
number of nitrous-related presentations to hospital emergency departments (EDs) in 
New South Wales (NSW) (1) and Melbourne (5) have led to concerns about a 
potentially emerging public health problem in Australia (1, 5). Most health sequelae 
associated with nitrous oxide use are a consequence of vitamin B12 depletion, and 
are neurological or haematological in nature (e.g. combined degeneration of the 
spinal cord, myelopathy and demyelinating polyneuropathy) (13). Without early 
intervention, B12 depletion has the potential to cause irreversible neurological 
damage (8, 10, 14). Deaths involving nitrous oxide are very rare, but can occur from 
hypoxia (often related to loss of consciousness while using gas masks or placing 
plastic bags over the head) (e.g. 15) or misadventure (e.g. falls, injuries) (16). 
2
Adding to the concern about use of this inhalant, the Global Drug Survey recently 
reported that among over 17,000 participants who reported recent nitrous oxide use, 
3% reported “persistent numbness/tingling (paraesthesia)” (17) – symptoms 
potentially indicative of vitamin B12 depletion. 
Given preliminary indications that use and harms associated with nitrous oxide may 
be increasing, there is a need for a greater understanding of the prevalence and 
correlates of use to help inform harm reduction initiatives. This bulletin examines 
trends in the use of nitrous oxide among samples of people who regularly use ecstasy 
and other illicit stimulants surveyed as part of the Western Australia (WA) Ecstasy 
and Related Drugs Reporting System (EDRS) between 2003-2019. It also 
investigates correlates of self-reported recent (past six month) use of nitrous oxide 
among the 2019 national EDRS sample. 
Method
This bulletin draws on WA and national data from the 2003-2019 EDRS. The EDRS 
has been conducted annually in all Australian jurisdictions since 2003. The structured 
interviews, which were conducted face-to-face, asked participants about a range of 
topics, including their demographic characteristics, drug consumption, perceptions of 
the illicit drug market, health, crime, and risk and harm reduction behaviours. The 
eligibility criteria were: (1) aged at least 17 years old (16 in WA) (changed to 18 years 
for all jurisdictions in 2020); (2) have used ecstasy/MDMA on at least six occasions in 
the preceding six months (expanded to other illicit stimulant drugs from 2012); and (3) 
have been a resident of the capital city in which the interview took place for the 
preceding 12 months. Full details for the background and methods are available for 
download here.
This bulletin examines data collected on self-reported use of nitrous oxide. 
Descriptive statistics were run to determine the percentage of respondents reporting 
recent use across data collection years, the frequency of use among recent 
consumers, and the quantity of nitrous oxide being used in single sessions (in bulbs) 
(Figures 1-6). To examine correlates, bivariable analyses were first run to investigate 
associations between key demographic/drug use characteristics and the outcome 
variable (self-reported recent use of nitrous oxide) among the 2019 national sample 
(Table 1). The national sample was used to increase the number of cases available 
for analysis. Candidate variables for the multivariable analyses in Table 2 included 
demographic or drug use variables with significant bivariable tests in Table 1. 
Bivariable and multivariable logistic regressions determined unique correlates of self-
reported recent nitrous oxide use (Table 2). Chi-Square Tests of Independence were 
performed to investigate multicollinearity between categorical variables (e.g. studying 
and tertiary qualifications).
Results
Recent (past six month) use
The proportion of WA EDRS participants who self-reported recent use of nitrous 
oxide has steadily increased in the past decade. As shown in Figure 1, this upward 
trend is also observed in the national data.






























































Median days of recent (past six month) use 
In 2019, among recent WA consumers (n=61), nitrous oxide was used on a median 
of 10 occasions in the preceding six month period (IQR=3-24, range=1-80); a 
significant increase from three occasions in 2018 (IQR=1-10, range=1-50, p=0.001) 
As evident in Figure 2, 2019 marks the highest frequency of use recorded since 
data collection commenced. 





























































Note. Due to a small sample size in 2011 and low numbers reporting recent nitrous oxide use (n≤5), data for this year has been 
supressed. Y axis reduced to 12 days to improve visibility of trends. **p<.010 for 2018 vs 2019. 
High frequency use (at least weekly) 
In 2019, a quarter of recent WA consumers reported at least weekly use in the 
preceding six month period; a significant increase from 10% in 2018 (p=0.030) and 
the highest proportion on record for the WA EDRS. The percentage reporting 
weekly use in WA also exceeded the national percentage in 2019 (Figure 3). 
Figure 3: The percentage of nitrous oxide consumers reporting weekly or 
more frequent nitrous oxide use, 2003-2019
Note. Due to a small sample size in 2011 (associated with a global ecstasy shortage) and low numbers reporting recent nitrous oxide use 
(n≤5), data for this year has been supressed. Y axis reduced to 50 days to improve visibility of trends. *p<.050 for 2018 vs 2019.
Typical quantity per session
In 2019, the median amount used in a ‘typical’ session among WA consumers was 
10 bulbs (IQR=5-25, range=1-100), consistent with previous data collection years 
(e.g. 2018 median=10, IQR=4-50, range=1-300). The median quantity observed in 
WA was significantly higher than the national median in 2019 (p=0.001) (Figure 4).
Figure 4: Average number of bulbs used in a ‘typical’ session in the six 






































































































































Note. Due to a small WA sample size in 2011 (associated with a global ecstasy shortage) and low numbers reporting recent nitrous
oxide use (n≤5), data for this year has been supressed. Y axis reduced to 50 bulbs to improve visibility of trends. 
Maximum quantity per session
In 2019, the median ‘maximum’ amount used in a session among WA 
consumers was 25 bulbs (IQR=11-50, range=1-300); a non-significant increase 
from 20 bulbs in 2018 (IQR=4-50, range=1-500; p=0.185.) The maximum 
amount used in WA has been higher than the national median for the past 
seven reporting years (Figure 5).

















































































Note. Due to a small WA sample size in 2011 (associated with a global ecstasy shortage) and low numbers reporting recent 
nitrous oxide use (n≤5), data for this year has been supressed. Y axis reduced to 50 bulbs to improve visibility of trends. 
Figure 6 presents the percentage of recent consumers who reported using ≥20 
bulbs in a ‘typical’ session (i.e. ‘heavy’ use). While there is no clear trend line, 
43% of recent WA consumers reported using to this level in 2019; the highest 
proportion since data collection commenced.









































































Note. Due to a small WA sample size in 2011 and low numbers reporting recent nitrous oxide use (n≤5), data for this year has 
been supressed. Unlike alcohol, there are no recommended guidelines/levels of nitrous oxide use to reduce the risk of harm. 
Thus, the ‘heavy’ use threshold was chosen as 20 bulbs was above the typical median for most WA reporting years and could 
be reasonably argued to be ‘heavy’ by most standards, regardless of the frequency of use. 
Table 1: Demographic characteristics of the 2019 national EDRS sample 
according to self-reported recent use of nitrous oxide
Demographic 
characteristics





























































































































































































































aAmong those aged ≥18 years old. *p<0.050; **p<0.010; ***p<0.001.
Correlates of use (bivariable and multivariable analysis)
Among the 2019 national EDRS sample, 53% (n=424) reported recent use of 
nitrous oxide. Bivariable logistic regression analyses found respondents from 
NSW (as compared to QLD), younger participants, males, those who had not 
(yet) completed tertiary qualifications, those who were studying at university, 
and those with lower income were at significantly greater odds of reporting 
recent nitrous oxide use (Table 1). 
As outlined in the methods, candidate variables for the multivariable analysis 
were determined by bivariable significance in Table 1. After controlling for other 
variables, only jurisdiction, age and gender uniquely predicted recent use of 
nitrous oxide, and younger age was the strongest correlate identified in the 
model (Table 2).
Table 2: Correlates of self-reported recent use of nitrous oxide (multivariable 
logistic regression)
Discussion
The findings presented in this bulletin show some increasing trends in nitrous
oxide use amongst WA EDRS samples, in terms of any recent use, the frequency
of recent use, and to a lesser extent, the maximum amount of bulbs being used
per session. Whilst the WA findings appear consistent with a general upward trend
in the national EDRS data, it is important to emphasise that the EDRS recruits a
non-probability convenience sample. Thus, the findings cannot be generalised to
the wider population of people who regularly use stimulants in Australia, and
unfortunately, there are no known population-based surveys to triangulate these
findings with as the National Drug Strategy Household Survey (NDSHW) does not
ask specifically about the use of nitrous oxide (18). Additionally, the trends
observed in the EDRS findings could reflect sample differences across data
collection years (e.g. younger samples being recruited, given age was associated
with recent use in the multivariable analysis).


























































































































































Bivariable Model χ2 (16) = 134.665, p<0.001. Adjusted R square = 0.170 (Cox & Snell), 0.227 (Nagelkerke). Hosmer-Lemeshow
goodness of fit test, p=0.177, n=724, missing=73. AOR, adjusted odds ratio; CI, confidence interval. aAmong those aged ≤18 years 
old. *p<0.050; **p<0.010; ***p<0.001.
However, while the median age of the WA sample significantly declined between 
2019 and 2018, the median has consistently ranged between 19 and 20 years old 
since 2014, and the national median has shown no declining trend in age 
(consistently ranging between 20-22 years old). There also has not been an 
increase in the proportion of males in WA or national EDRS samples – another 
correlate of nitrous oxide use identified in the multivariable analysis. Thus, there 
are no obvious indications that the upward trends identified reflect sample 
differences in terms of age and gender. Additionally, the findings in this bulletin are 
consistent with other preliminary indications of increasing recreational use in 
Australia (1, 5, 6). Thus, limitations to the data notwithstanding, the findings in this 
bulletin warrant consideration. 
The nitrous oxide trends identified in the EDRS samples raise concern for a 
number of reasons. Firstly, higher rates of use, and riskier patterns of use (in 
terms of frequency of use and quantity being used) heighten concern about the 
risk of associated harm. As mentioned in the introduction, there is a growing 
number of case reports/series documenting significant, and in some cases 
enduring, neurological consequences associated with recreational nitrous oxide 
use (3-5, 9-13, 19-21) and there have been concerns about increasing 
presentations to some EDs in Australia (1, 5). Additionally, the Global Drugs 
Survey found a small (3%, n=561) but significant proportion of respondents who 
had used nitrous reported symptoms indicative of neurological damage, and 
identified a strong dose dependent relationship (17). This raises concern that 
some EDRS participants could also be experiencing adverse effects associated 
with their use, but data on this was unfortunately not collected. 
Secondly, the high number of bulbs used by some respondents in a single session 
raises questions about the route of administration (ROA) being used. For example, 
did participants first dispense the gas into a balloon (which is considered a safer 
ROA (22)) or were they inhaling directly from the bulbs or dispenser? 
Unfortunately data about the ROA was not collected by the EDRS, but is of 
interest because certain ROAs can increase the risk of acute harms, such as cold 
burns/frostbite (23), ruptures in the lung (24) and hypoxia (25, 26). Since nitrous 
can also cause dizziness, perceptual and psychological disturbances, and loss of 
consciousness, there is also an acute risk of injury due to falling or misadventure. 
In 2018, a Surfers Paradise schoolie reportedly died after plunging from a balcony 
after consuming nitrous oxide (16). 
Thirdly, the upward trends observed in the data are concerning because nitrous 
oxide remains very easy to access at low cost and in bulk. Moreover, a quick 
Google search (conducted June 25, 2020) identified at least 10 different 24/7 
nitrous oxide delivery services in Perth which supply bulbs, dispensers and 
balloons. These services are clearly marketed for party rather than professional 
use, and some also offer a variety of other “party supplies” such as smoking/drug 
paraphernalia (e.g. bongs, scales, baggies, rolling papers) and “munchie” snacks. 
Some of these delivery services appear to have an active social media presence 
(with thousands of followers) and promote bulk buy specials, Facebook 
competitions/promotions (e.g. tag your friends for discounts) and their physical 
presence at different events, including schoolies/leavers. Promotion of these 
services is a concern as it may encourage increased uptake of use, and heavier 
patterns of use. Thus, not only is it inevitable that nitrous oxide will continue to 
be used recreationally, popularity may continue to increase.
The finding that living in NSW (relative to Queensland), younger age, and male 
gender predicted recent nitrous oxide use is not surprising, but warrants 
consideration. Firstly, the low cost and easy access clearly makes nitrous oxide 
an appealing drug for young people. However, heavy and/or prolonged use 
among young people raises concern about the impact on the developing brain 
(27), further highlighting the importance of early intervention. Secondly, while 
male gender was associated with increased odds of reporting nitrous oxide use 
(consistent with other studies, e.g. (27)), almost half of the female participants 
also reported use. This is noteworthy as there is some evidence to suggest 
females of reproductive age may be at greater risk of experiencing neurological 
complications associated with nitrous oxide use, purportedly due to a higher 
prevalence of B12 deficiencies (e.g. 17). Lastly, the finding that residence in 
NSW was associated with greater odds of reporting recent use is consistent with 
ED data showing a sharp increase of presentations involving nitrous oxide since 
2016 (1). However, it is important to note that recent nitrous oxide use was a 
majority behaviour in samples from all jurisdictions except Tasmania, South 
Australia and the Northern Territory. Thus, the potential for harm is certainly not 
limited to NSW.
Overall, these findings have multiple implications for harm reduction and supply 
control. Firstly, there may be a need to review existing regulation of nitrous oxide 
in Australia. However, regulations vary across jurisdictions. For example, it is an 
offence to sell/supply nitrous oxide for recreational use in the Northern Territory, 
NSW, Victoria and South Australia (SA) (28-30) (although this is very difficult to 
enforce), and SA recently also made it an offence to sell to people under 18, sell 
between the hours of 10pm and 5am and make nitrous oxide visible or 
accessible in retail stores (30). Other jurisdictions, including WA, should consider 
the strengths and weaknesses of implementing similar restrictions to SA, 
particularly to reduce the risk of 24/7 delivery services, marketed at young 
people, attracting new users with their online presence and promotions. Indeed, 
youth advocates have already made calls for this type of improved regulation 
(e.g. 31). However, others have expressed concern that stricter regulation on 
bulbs and dispensers could trigger riskier methods of use, such as inhalation 
from tanks and masks which provide continuous delivery of nitrous oxide, even 
when loss of consciousness occurs (unlike administration via balloons) (22). 
There is also a risk that regulatory changes could inadvertently increase demand 
by drawing more attention to their recreational value (32). 
While there is still merit in reviewing existing regulation to try and curb growing 
popularity and reduce high risk patterns of use, as others have argued (e.g. 17), 
the primary focus of public health efforts should perhaps be on education and 
harm reduction. This could include targeted campaigns aimed at raising 
awareness of the risks, protective behaviours and early neurological symptoms 
(e.g. tinging, numbness). As mentioned previously, evidence suggests early 
diagnosis and intervention is critical in preventing permanent damage (8, 10, 14). 
While there are already numerous online resources providing harm reduction 
information on nitrous oxide (e.g. Dancewize, the Australian Drug Foundation and 
Drug Aware), consideration should be given to adding advice on dose limits per 
session and frequency of use. Improved promotion and delivery of online 
resources should also be considered. Lastly, clinicians in both primary and tertiary 
healthcare settings should be aware of potentially increasing trends in use, 
particularly among young people, and alert to the variety of presenting symptoms 
associated with nitrous oxide use.
Conclusion
Increasing trends in reports of recent nitrous oxide use, days of use and typical 
use of over 20 bulbs per session among EDRS samples raises concern about the 
risk of associated harms. While there are implications for reviewing existing 
regulation of this inhalant (particularly with regards to delivery 
services/promotions), in recognition that nitrous oxide use will continue regardless 
of regulation and policing, responses should include public health interventions 
that focus on education and harm reduction. There are also implications for more 
closely monitoring the use of this drug in Australia, and investigating consumer 
knowledge about the associated risks.
References
1. Bethmont A, Harper CE, Chan BS, Dawson AH, McAnulty J. Increasing illicit use of nitrous oxide in 
presentations to NSW emergency departments. Med J Aust. 2019;211(9):429-.e1.
2. Kaar SJ, Ferris J, Waldron J, Devaney M, Ramsey J, Winstock AR. Up: The rise of nitrous oxide abuse. 
An international survey of contemporary nitrous oxide use. J Psychopharm. 2016;30(4):395-401.
3. Zheng D, Ba F, Bi G, Guo Y, Gao Y, Li W. The sharp rise of neurological disorders associated with 
recreational nitrous oxide use in China: A single-center experience and a brief review of Chinese 
literature. J Neurol. 2020;267(2):422-9.
4. Algahtani H, Shirah B, Abdelghaffar N, Abuhawi O, Alqahtani A. Nitrous oxide recreational abuse 
presenting with myeloneuropathy and mimicking Guillain-Barre syndrome. Intractable Rare Dis Res. 
2020;9(1):54-7.
5. McArdle DJT, Gaillard F. Pernicious azotaemia? A case series of subacute combined degeneration of 
the cord secondary to nitrous oxide abuse. J Clin Neurosci. 2020;72:277-80.
6. Ferris J, Puljevic C, Wilson H, Winstock A. Recreational use of nitrous oxide: Is it really harmless?2020. 
Available from: https://stories.uq.edu.au/medicine/blog/2019/recreational-use-of-nitrous-oxide/index.html.
7. Randhawa G, Bodenham A. The increasing recreational use of nitrous oxide: History revisited. Br J 
Anaesth. 2016;116(3):321-4.
8. Thompson AG, Leite MI, Lunn MP, Bennett DLH. Whippits, nitrous oxide and the dangers of legal highs. 
Pract Neurol. 2015;15(3):207-9.
9. Blair C, Tremonti C, Edwards L, Haber P, Halmagyi M. 118 Case series: Subacute combined 
degeneration of the spinal cord in vitamin B12-replete recreational nitrous oxide abusers. J Neurol
Neurosurg Psychiatry. 2019;90(e7):A38.2-A9.
References continued
10. Lan S-Y, Kuo C-Y, Chou C-C, Kong S-S, Hung P-C, Tsai H-Y, et al. Recreational nitrous oxide abuse 
related subacute combined degeneration of the spinal cord in adolescents – A case series and literature 
review. Brain Dev. 2019;41(5):428-35.
11. Gupta S. Recreational nitrous oxide abuse causing ischemic stroke in a young patient: A rare case 
report. Cureus. 2018;10(12).
12. Johnson K, Mikhail P, Kim MG, Bosco A, Huynh W. Recreational nitrous oxide-associated neurotoxicity. 
J Neurol Neurosurg Psychiatry. 2018;89(8):897-8.
13. Oussalah A, Julien M, Levy J, Hajjar O, Franczak C, Stephan C, et al. Global burden related to nitrous 
oxide exposure in medical and recreational settings: A systematic review and individual patient data 
meta-analysis. J Clin Med. 2019;8(4).
14. Garakani A, Jaffe RJ, Savla D, Welch AK, Protin CA, Bryson EO, et al. Neurologic, psychiatric, and other 
medical manifestations of nitrous oxide abuse: A systematic review of the case literature. Am J Addict. 
2016;25(5):358-69.
15. Bäckström B, Johansson B, Eriksson A. Death from Nitrous Oxide. J Forensic Sci. 2015;60(6):1662-5.
16. Bruce-Smith A. Father of dead schoolie calls for 'nangs' to be regulated2018. Available from: 
https://10daily.com.au/news/australia/a181213dnr/father-of-dead-schoolie-calls-for-nangs-to-be-
regulated-20181214.
17. Winstock AR, Ferris JA. Nitrous oxide causes peripheral neuropathy in a dose dependent manner 
among recreational users. J Psychopharm. 2019;34(2):229-36.
18. Australian Institute of Health and Welfare. National drug strategy household survey 2016: Detailed 
findings. 2016.
19. Middleton JA, Roffers JA. Peripheral neuropathy due to recreational use of nitrous oxide presenting after 
an ankle sprain with foot drop. Orthopedics. 2018;41(3):E432-E3.
20. Johnson K, Philopatir M, Kim MG, Bosco A, Huynh W. Recreational nitrous oxide-associated 
neurotoxicity. J Neurol Neurosurg Psychiatry. 2018;89(8):897.
21. Egan W, Steinberg E, Rose J. Vitamin B12 deficiency-induced neuropathy secondary to prolonged 
recreational use of nitrous oxide. Am J Emerg Med. 2018;36(9):1717.e1-.e2.
22. Jay M. Nitrous oxide: Recreational use, regulation and harm reduction. Drugs and Alcohol Today. 
2008;8(3):22-5.
23. Hwang JCF, Himel HN, Edlich RF. Frostbite of the face after recreational misuse of nitrous oxide. Burns. 
1996;22(2):152-3.
24. McDermott R, Tsang K, Hamilton N, Belton M. Recreational nitrous oxide inhalation as a rare cause of 
spontaneous pneumomediastinum. BMJ Case Rep. 2015;2015:bcr2015209750.
25. Backstrom B, Johansson B, Eriksson A. Death from nitrous oxide. J Forensic Sci. 2015;60(6):1662-5.
26. Ng J, O'Grady G, Pettit T, Frith R. Nitrous oxide use in first-year students at Auckland University. The 
Lancet. 2003;361(9366):1349-50.
27. Ehirim EM, Naughton DP, Petróczi A. No laughing matter: Presence, consumption trends, drug 
awareness, and perceptions of "hippy crack" (nitrous oxide) among young adults in England. Front 
Psychiatry. 2018;8:312-.
28. Drugs, Poisons and Controlled Substances Act 1981: Version 129  2020 1 July 2020. Available from: 
https://www.legislation.vic.gov.au/in-force/acts/drugs-poisons-and-controlled-substances-act-1981/129.
29. Thomas J, Jones R. Doctors warn of dangerous rise in use of 'nangs'2017. Available from: 
https://www.abc.net.au/news/2017-10-16/doctors-warn-of-dangerous-use-of-nangs-or-nitrous-
oxide/9046574.




31. Ross H, Sapwell G, White L. Youth advocates call for better regulation of nitrous oxide canisters known 
as 'nangs'2018. Available from: https://www.abc.net.au/news/2018-12-13/calls-for-better-regulation-of-
nitrous-oxide-canisters/10584356.
32. Lee N, Bright S. Explainer: What is nitrous oxide (or nangs) and how dangerous is it?2018. Available 
from: https://theconversation.com/explainer-what-is-nitrous-oxide-or-nangs-and-how-dangerous-is-it-
108019.
Participating researchers and research centres
• Antonia Karlsson, Julia Uporova, Daisy Gibbs, Rosie Swanton, Olivia Price, 
Georgia Kelly, Professor Louisa Degenhardt, Professor Michael Farrell and Dr 
Amy Peacock, National Drug and Alcohol Research Centre, University of New 
South Wales;
• Brittany Ciupka, Amy Kirwan, Cristal Hall and Professor Paul Dietze, Burnet 
Institute Victoria;
• Callula Sharman and Associate Professor Raimondo Bruno, School of 
Psychology, University of Tasmania;
• Jodie Grigg and Professor Simon Lenton, National Drug Research Institute, 
Curtin University, Western Australia; and
• Catherine Daly, Jennifer Juckel, Leith Morris and Dr Caroline Salom, Institute 
for Social Science Research, The University of Queensland.
Other acknowledgements
• We would like to thank all the participants who were interviewed for the EDRS. 
• The EDRS is funded by the Australian Government under the Substance 
Misuse Prevention and Service Improvement Grants Fund.
Suggested citation
Grigg, J. & Lenton, S. (2020). Increasing trends in self-reported use of nitrous 
oxide among WA EDRS samples. Drug Trends Bulletin Series. Sydney: National 
Drug and Alcohol Research Centre, University of New South Wales.
